R to @EMA_News: To support development and earlier assessment of medicines that address unmet medical needs for #cancer patients
➡️ 7 were reviewed in view of a conditional marketing authorisation
➡️ 1 had accelerated assessment
➡️ 2 were part of the #PRIME scheme

#EMAPresser

🐦🔗: https://nitter.cz/EMA_News/status/1747253499493261624#m

[2024-01-16 13:44 UTC]